The Prime Minister has decided to use over 8.8 billion VND from the national COVID-19 vaccine fund to support the first and second phase of clinical trials of COVIVAC vaccine, which has been developed by the Health Ministry’s Institute of Vaccines and Medical Biologicals (IVAC) since May 2020.
Six volunteers participating in the human trials of Vietnam’s second homegrown candidate vaccine Covivac got their second shots of the vaccine on April 12.
Fifteen more volunteers have been inoculated with Vietnam’s second homegrown candidate vaccine COVIVAC on March 23 as part of its ongoing human trials.
Six out of 120 volunteers have been injected with Vietnam’s second homegrown candidate vaccine COVIVAC, as human trials began at the Hanoi Medical University on March 15.
The Institute of Vaccines and Medical Biologicals (IVAC), based in central Khanh Hoa province, has proposed the Ministry of Health allow human trials of its COVID-19 vaccine to begin in January, two months ahead of schedule.
The IVACFLU-S vaccines, which have been produced in Vietnam to protect against seasonal flu such as A/H1N1, A/H3N2, and B, are now available on the market, according to the Institute of Vaccines and Medical Biologicals under the Ministry of Health.
The IVACFLU-S vaccines, which have been produced in Việt Nam to protect against seasonal flu such as A/H1N1, A/H3N2, and B, are now available on the market, the Institute of Vaccines and Medical Biologicals under the Ministry of Health has said.
Two influenza vaccines IVACFLU-S and IVACFLY, which were successfully produced in Vietnam, were introduced at a workshop held by the Institute of Vaccines and Medical Biologicals (IVAC) and the Programme for Appropriate Technology in Health (PATH) in the central province of Khanh Hoa on September 25.
The Institute of Vaccines and Medical Biologicals (IVAC) has completed the clinical trials of two types of seasonal influenza vaccine, which are expected to receive approval for commercial use in 2019, said Dr Le Van Be, head of the institute.
he Institute of Vaccines and Medical Biologicals (IVAC) of Vietnam has announced the successful production of inactivated seasonal influenza vaccine (IVACFLU-S) for commercial use.
Health
